Literature DB >> 8192735

The United States needs a health system like other countries.

W A Glaser1.   

Abstract

Every developed country except the United States has a comprehensive health system for coverage, service provision, and finance. Social policy in the United States once was guided by thinkers who realized this, and the Social Security system--complete except for health insurance--resulted. The climate of thinking changed, and health policy for some time has been dominated by classical economists who argue that free competitive markets will solve all problems. They justify their arguments by claiming that the only alternative is full government takeovers of service and financing, as in Canada. While this debate has dragged along, problems in the United States have become grave. Instead of reviving the institutional economics and social policies that once served the United States well, the Clinton administration has turned policy over to devotees of managed competition. But the problem is how to organize the country, and national health insurance--easily observed in other countries--is superior to the current chaos and free-market utopias in the United States. Important aims would be achieved, such as expanding coverage, obtaining stable revenue, and containing costs. Important political barriers can be overcome, such as resistance by small business. Such a health system includes machinery for setting goals and implementing results, involving collaboration among providers, payers, and government.

Mesh:

Year:  1993        PMID: 8192735

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  3 in total

1.  Commentary: recent reforms in the British National Health Service--lessons for the United States.

Authors:  W W Holland; C Graham
Journal:  Am J Public Health       Date:  1994-02       Impact factor: 9.308

2.  The strange career of managed competition: from military failure to medical success?

Authors:  H Waitzkin
Journal:  Am J Public Health       Date:  1994-03       Impact factor: 9.308

Review 3.  General practice.

Authors:  C Silagy
Journal:  BMJ       Date:  1994-10-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.